Journal of Clinical and Cellular Immunology : Citations & Metrics Report
Articles published in Journal of Clinical and Cellular Immunology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical and Cellular Immunology has got h-index 42, which means every article in Journal of Clinical and Cellular Immunology has got 42 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical and Cellular Immunology.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
30 | 31 | 30 | 59 | 28 | 11 | 35 | 56 | 95 | 105 | 101 | 105 | 64 | 15 | 3 |
Research, Review articles and Editorials |
2 | 13 | 8 | 23 | 18 | 8 | 25 | 35 | 54 | 86 | 79 | 35 | 23 | 14 | 3 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 18 | 22 | 22 | 10 | 3 | 10 | 21 | 39 | 6 | 9 | 7 | 1 | 1 | 0 |
Conference proceedings |
0 | 16 | 15 | 6 | 0 | 98 | 178 | 206 | 171 | 160 | 195 | 156 | 74 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
653 | 826 | 931 | 1079 | 1018 | 971 | 871 | 851 | 753 | 550 | 276 | 145 | 43 | 40 | 0 |
| Journal total citations count | 8361 |
| Journal impact factor | 24.12 |
| Journal 5 years impact factor | 31.14 |
| Journal cite score | 30.45 |
| Journal h-index | 42 |
| Journal h-index since 2019 | 32 |
Important citations (1511)
Hundeshagen as. die individuelle aktivität des interferon-typ-i-signalwegs in immunzellen von patienten mit multipler sklerose in assoziation mit dem krankheitsverlauf unter therapie (doctoral dissertation). |
|
Kolyada ti, zelenska bp, tupotilov ab (2016) modern methods of investigation of biomarkers for multiple sclerosis. annalee mechnikovskogo Ñ–nstitutu 2016: 27-33. |
|
Pouragahi s, nassiri-asl m, sahraian ma, sadeghi m, banki a, et al. (2016) utility of myelin basic protein as an early prognostic biomarker in multiple sclerosis. iranian red crescent medical journal. |
|
Kakhki mp, nikravesh a, kokhaei p (2013) micrornas as diagnostic and therapeutic targets in multiple sclerosis. advances in neuroimmune biology 4: 67-76. |
|
Balabanov p, haas m, elferink a, bakchine s, broich k (2014) addressing the regulatory and scientific challenges in multiple sclerosis–a statement from the eu regulators. multiple sclerosis journal 20: 1282-1287. |
|
Hecker m, thamilarasan m, koczan d, schröder i, flechtner k, et al. (2013) microrna expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients. international journal of molecular sciences 14: 16087-16110. |
|
Hundeshagen as. the individual activity of the interferon-type i signaling pathway in immune cells of patients with multiple sclerosis in association with the course of the disease under therapy (doctoral dissertation). |
|
Kolyada ti, zelenska bp, tupotilov ab (2016) modern methods of investigation of biomarkers for multiple sclerosis. annalee mechnikovskogo Ñ–nstitutu 2016 : 27-33. |
|
Pouragahi s, nassiri-asl m, sahraian ma, sadeghi m, banki a, et al. (2016) utility of myelin basic protein as an early prognostic biomarker in multiple sclerosis. iranian red crescent medical journal. |
|
Kakhki mp, nikravesh a, kokhaei p (2013) micrornas as diagnostic and therapeutic targets in multiple sclerosis. advances in neuroimmune biology 4: 67-76. |
|
Balabanov p, haas m, elferink a, bakchine s, broich k (2014) addressing the regulatory and scientific challenges in multiple sclerosis–a statement from the eu regulators. multiple sclerosis journal 20: 1282-1287. |
|
Hecker m, thamilarasan m, koczan d, schröder i, flechtner k, et al. (2013) microrna expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients. international journal of molecular sciences 14: 16087-16110. |
|
Amjadi o, abedini m, rafiei a, safaii s, ajami a, et al. (2015) interferon in autoimmune diseases: friend or foe. journal of mazandaran university of medical sciences 24: 414-430. |
|
Lorenzo pérez n. a modified peptide ligand derived from the human 60 kda cellular stress protein with therapeutic effect in experimental models of autoimmune arthritis (doctoral dissertation). |
|
Brasil-costa i, silva mj, oliveira dd, freitas fb, costa ib, et al. (2016) avaliação diagnóstica das infecções por vÃrus epstein-barr, parvovÃrus b19 e vÃrus linfotrópico de células t humanas em pacientes portadores de lúpus eritematoso sistêmico em hospital de referência do estado do pará, brasil. revista pan-amazônica de saúde 7: 167-176. |
|
Amjadi o, abedini m, rafiei a, safaii s, ajami a, et al. (2015) interferons in autoimmune diseases: friend or foe. journal of mazandaran university of medical sciences 24: 414-430. |
|
Vojdani a, pollard km, campbell aw. special issue on environmental triggers and autoimmunity. |
|
Pinna s. proteomic analysis of human plasma and peripheral blood mononuclear cells in systemic lupus erythematosus patients. |
|
Singh sp, wal p, wal a, srivastava v, tiwari r, sharma rd. understanding autoimmune disease: an update review. |
|
Ieronymaki m. immunological and conformational characterization of synthetic peptide probes for autoimmune diseases (doctoral dissertation, cergy-pontoise). |
|